Alterity Therapeutics Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Alterity Therapeutics Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3% to $4,019,285. Profit margin reached -476%. Total operating expenses were $23,406,690.

Profit Margin

Alterity Therapeutics Limited (NASDAQ:ATHE): Profit margin
2015 176.84K -5.88M -3327.87%
2016 142.65K -7.72M -5418.28%
2017 132.39K -7.54M -5696.6%
2018 201.17K -8.26M -4108.75%
2019 108.53K -12.33M -11367.29%
2020 0 -9.69M
2021 3.25M -15.30M -470.47%
2022 3.53M -12.84M -363.18%
2023 3.91M -13.80M -352.54%
2024 4.01M -19.12M -475.79%

ATHE Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
4.01M3.91M3.53M3.25M0108.53K201.17K132.39K142.65K176.84K
Cost of revenue
214.30K285.06K251.77K269.96K112.42K226.12K166.22K21.32K180.24K257.29K
Gross profit
3.80M3.63M3.28M2.98M-112.42K-117.59K34.95K111.06K-37.58K-80.45K
Operating exp.
Research and development
18.64M13.19M14.74M12.28M10.09M12.98M6.69M5.70M9.58M12.29M
Selling and marketing
-9.67K51.48K00093.25K105.27K0-87.85K87.85K
Total operating expenses
23.40M17.34M15.13M14.73M10.06M12.47M11.09M6.77M8.48M10.61M
Operating income
-19.60M-14.63M-10.70M-12.13M-10.41M-8.98M-6.06M-6.88M-8.58M-10.43M
Other income (expenses), net
524.33K904.68K2.35M-591.33K428.68K26.96K2.63M-786.28K615.29K4.68M
Income before tax
-19.07M-13.70M-12.77M-15.30M-10.05M-12.33M-8.26M-7.54M-7.72M-5.88M
Income tax expense
46.08K104.45K70.00K210.63K-362.18K-349.06K270.86K660.21K-857.24K-170.97K
Net income
-19.12M-13.80M-12.84M-15.30M-9.69M-12.33M-8.26M-7.54M-7.72M-5.88M
Earnings per share
Basic EPS
-0.00-0.00-0.00-5.41-6.5-12.02-9.3-8.48-8.69-7.02
Diluted EPS
-0.00-0.00-0.00-5.41-6.5-12.02-9.3-8.48-8.69-7.02
Data sourceData sourceData sourceData sourceData source